QIAGEN (QGEN)
(Delayed Data from NYSE)
$44.91 USD
-0.66 (-1.45%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $44.92 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Qiagen (QGEN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$52.23 | $60.00 | $45.00 | 14.61% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Qiagen comes to $52.23. The forecasts range from a low of $45.00 to a high of $60.00. The average price target represents an increase of 14.61% from the last closing price of $45.57.
Analyst Price Targets (12)
Broker Rating
Qiagen currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 57.14% and 7.14% of all recommendations. A month ago, Strong Buy made up 57.14%, while Buy represented 7.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Berenberg Bank | Odysseas Manesiotis | Strong Buy | Strong Buy |
8/2/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
8/1/2024 | Cowen & Co. | Daniel Brennan | Hold | Hold |
8/1/2024 | Not Identified | Not Identified | Hold | Hold |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
6/28/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
6/27/2024 | Not Identified | Not Identified | Hold | Strong Buy |
6/18/2024 | UBS | John N Sourbeer | Hold | Hold |
5/1/2024 | William Blair | Andrew F Brackmann | Hold | Hold |
2/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 14 |
Average Target Price | $52.23 |
LT Growth Rate | 6.50% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | 0.54 |
QGEN FAQs
QIAGEN N.V. (QGEN) currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for QIAGEN N.V. (QGEN) is $52.23. The current on short-term price targets is based on 8 reports.
The forecasts for QIAGEN N.V. (QGEN) range from a low of $45 to a high of $60. The average price target represents a increase of $16.30 from the last closing price of $44.91.
The current UPSIDE for QIAGEN N.V. (QGEN) is 16.30%
Based on short-term price targets offered by 12 analysts, the average price target for Qiagen comes to $52.23. The forecasts range from a low of $45.00 to a high of $60.00. The average price target represents an increase of 14.61% from the last closing price of $45.57.